DE69019859D1 - Chinolon-Derivate und deren Salze, Verfahren zu deren Herstellung und diese enthaltende antibakterielle Wirkstoffe. - Google Patents

Chinolon-Derivate und deren Salze, Verfahren zu deren Herstellung und diese enthaltende antibakterielle Wirkstoffe.

Info

Publication number
DE69019859D1
DE69019859D1 DE69019859T DE69019859T DE69019859D1 DE 69019859 D1 DE69019859 D1 DE 69019859D1 DE 69019859 T DE69019859 T DE 69019859T DE 69019859 T DE69019859 T DE 69019859T DE 69019859 D1 DE69019859 D1 DE 69019859D1
Authority
DE
Germany
Prior art keywords
group
substituted
hydrogen
atom
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69019859T
Other languages
English (en)
Other versions
DE69019859T2 (de
Inventor
Takashi Yatsunami
Hitoshi Yamamoto
Yasuhiro Kuramoto
Norihiro Hayashi
Akira Yazaki
Satoshi C O Wakunaga Sei Inoue
Shuichiro Noda
Hirotaka Amano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakunaga Pharmaceutical Co Ltd
Original Assignee
Wakunaga Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1079523A external-priority patent/JPH02258783A/ja
Application filed by Wakunaga Pharmaceutical Co Ltd filed Critical Wakunaga Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69019859D1 publication Critical patent/DE69019859D1/de
Publication of DE69019859T2 publication Critical patent/DE69019859T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69019859T 1989-03-30 1990-03-30 Chinolon-Derivate und deren Salze, Verfahren zu deren Herstellung und diese enthaltende antibakterielle Wirkstoffe. Expired - Fee Related DE69019859T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1079523A JPH02258783A (ja) 1989-03-30 1989-03-30 キノロン誘導体及びその塩
JP8232289 1989-03-31

Publications (2)

Publication Number Publication Date
DE69019859D1 true DE69019859D1 (de) 1995-07-13
DE69019859T2 DE69019859T2 (de) 1995-10-05

Family

ID=26420539

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69019859T Expired - Fee Related DE69019859T2 (de) 1989-03-30 1990-03-30 Chinolon-Derivate und deren Salze, Verfahren zu deren Herstellung und diese enthaltende antibakterielle Wirkstoffe.

Country Status (4)

Country Link
US (1) US5153203A (de)
EP (1) EP0390215B1 (de)
AT (1) ATE123494T1 (de)
DE (1) DE69019859T2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407932A (en) * 1989-03-31 1995-04-18 Wakunaga Seiyaku Kabushiki Kaisha Quinolone derivatives and antibacterial agents containing the same
WO1992021659A1 (en) * 1991-05-28 1992-12-10 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative
GB9118183D0 (en) * 1991-08-23 1991-10-09 Solanki Kishor K Imaging of infections
WO1993013091A1 (en) * 1991-12-27 1993-07-08 Wakunaga Seiyaku Kabushiki Kaisha Novel quinolone derivative or salt thereof and antibacterial containing the same
TW252107B (de) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
ATE319710T1 (de) 2000-12-21 2006-03-15 Pharmacia & Upjohn Co Llc Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen
ES2186550B2 (es) * 2001-06-27 2003-11-16 Vita Lab Nuevos derivados de oxazolidinonas como antibacterianos.
WO2003031443A1 (de) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual action antibiotics
WO2003031441A1 (en) * 2001-10-04 2003-04-17 Morphochen Aktiengesellschaft Für Kombinatorische Chemie Multiple action compounds
EP2565178A1 (de) 2002-10-03 2013-03-06 Ono Pharmaceutical Co., Ltd. LPA-Rezeptorantagonisten
BRPI0409955A (pt) 2003-04-30 2006-04-25 Morphochem Ag Komb Chemie uso de antibióticos hìbridos de oxazolidinona - quinolina para o tratamento de antrax e outras infecções
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
US7246755B2 (en) * 2003-12-18 2007-07-24 Cepia, Llc Power sprayer
KR101176450B1 (ko) 2003-12-18 2012-08-30 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 옥사졸리디논-퀴놀론 혼성 항생제
US7498341B2 (en) * 2004-01-31 2009-03-03 Sanofi Aventis Deutschland Gmbh Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
PL2383271T3 (pl) * 2006-03-13 2013-12-31 Kyorin Seiyaku Kk Aminochinolony jako inhibitory GSK-3
MX2010002667A (es) * 2007-09-11 2010-04-01 Activx Biosciences Inc Cianoaminoquinolonas y tetrazoloaminoquinolonas como inhibidores de gsk-3.
BRPI0816814B1 (pt) 2007-09-12 2021-08-31 Kyorin Pharmaceutical Co. Ltd Composto, composição farmacêutica e uso de um composto
AU2010221990B2 (en) 2009-03-11 2015-06-04 Kyorin Pharmaceutical Co., Ltd. 7-cycloalkylaminoquinolones as GSK-3 inhibitors
CN104402902B (zh) * 2014-12-15 2016-05-18 河南大学 手性7-(哌嗪取代的吡唑醛缩异烟肼腙)氟喹诺酮羧酸衍生物及其制备方法和应用
MX2018015462A (es) 2016-06-15 2019-05-27 Wakunaga Pharma Co Ltd Derivado novedoso del acido piridonacarboxilico o su sal.
CN109912504B (zh) * 2019-04-04 2020-11-10 山东省联合农药工业有限公司 一种喹啉羧酸类化合物及其制备方法与用途
CN114163452A (zh) * 2021-12-24 2022-03-11 广东医科大学 一种1,3-恶嗪并1,3-恶唑衍生物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473568A (en) * 1983-03-01 1984-09-25 Warner Lambert Company Antibacterial thiazolidine or thiomorpholine substituted quinolines
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
DE3811341A1 (de) * 1987-10-09 1989-04-27 Bayer Ag In 7-stellung c-verknuepfte chinolon- und 1,8-naphthyridin-4-on-carbonsaeure und ein verfahren zu ihrer herstellung
EP0339406A1 (de) * 1988-04-19 1989-11-02 Hokuriku Pharmaceutical Co.,Ltd Derivate der Chinolin-3-carbonsäure, Verfahren zu ihrer Herstellung und diese Derivate enthaltende antibakterielle Zusammensetzung

Also Published As

Publication number Publication date
ATE123494T1 (de) 1995-06-15
EP0390215B1 (de) 1995-06-07
EP0390215A2 (de) 1990-10-03
DE69019859T2 (de) 1995-10-05
US5153203A (en) 1992-10-06
EP0390215A3 (de) 1991-07-24

Similar Documents

Publication Publication Date Title
DE69019859D1 (de) Chinolon-Derivate und deren Salze, Verfahren zu deren Herstellung und diese enthaltende antibakterielle Wirkstoffe.
MY100574A (en) 5-substituted-2-cyclopropyl-6, 8-difluoroquinoline derivatives and processes for preparation thereof
EP0256503A3 (en) Pyridinecarboxamide derivatives and their use as fungicide
ES8607287A1 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NO307255B1 (no) Nye forbindelser og antitumormidler
IL103944A (en) Piperazine derivatives, their preparation and pharmaceutical compositions containing them
DE69305276D1 (de) Arylglycinamidderivate, Verfahren zur deren Herstellung und deren Verwendung zur Therapie der Dysurie
DE69129175D1 (de) 1-Methylcarbapenemderivate und Verfahren zu ihrer Herstellung
DE3882438D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE67199T1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
ATE48994T1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
HU903266D0 (en) Process for producing amine-derivatives and pharmaceutical preparatives containing these compounds as active substance
MY109714A (en) Process for preparing 8-chloroquinolone derivatives
ATE18667T1 (de) Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung.
DE68911006D1 (de) Pharmakologisch-aktive Alkylthiobenzimidazol-Derivate und Verfahren zu deren Herstellung.
ATE160566T1 (de) Amphotere tricyclische verbindungen als antihistaminische und antiallergische mittel
DE69420514D1 (de) Cyclopropan-Derivate und diese enthaltende antivirale Mittel
ES8101646A1 (es) Un procedimiento para producir un compuesto opticamente ac- tivo
DE68911095D1 (de) Antitumor-Substanz, Verfahren zu deren Herstellung und diese enthaltende Antikrebsmittel.
GEP19960472B (en) Method of producing derivative of quinoline or its pharmaceutically acceptable ester, or their salts
FI903511A0 (fi) Pyrrolo (2,1-b) tiazolderivat.
MY104164A (en) Heterocyclic compounds.
TH19265A (th) อนุพันธ์เอสเทอร์และคาร์บาเมทของแอโซโลน

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee